VOLPI, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.958
EU - Europa 15.387
AS - Asia 7.236
SA - Sud America 935
AF - Africa 139
OC - Oceania 79
Continente sconosciuto - Info sul continente non disponibili 33
Totale 53.767
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.768
GB - Regno Unito 6.000
IT - Italia 2.872
SG - Singapore 2.029
CN - Cina 1.977
SE - Svezia 1.572
HK - Hong Kong 1.324
DE - Germania 1.107
UA - Ucraina 947
TR - Turchia 827
BR - Brasile 733
RU - Federazione Russa 629
FI - Finlandia 594
BG - Bulgaria 391
FR - Francia 346
KR - Corea 214
IN - India 165
ID - Indonesia 154
NL - Olanda 141
CA - Canada 107
VN - Vietnam 104
ES - Italia 103
PL - Polonia 92
CH - Svizzera 87
IE - Irlanda 84
JP - Giappone 80
AR - Argentina 74
MX - Messico 66
AU - Australia 65
IR - Iran 59
BE - Belgio 55
MY - Malesia 48
GR - Grecia 45
LT - Lituania 45
TH - Thailandia 44
PE - Perù 39
AT - Austria 36
PK - Pakistan 36
CZ - Repubblica Ceca 34
RO - Romania 33
ZA - Sudafrica 31
PT - Portogallo 29
RS - Serbia 29
CL - Cile 26
DK - Danimarca 26
EG - Egitto 26
EU - Europa 25
IL - Israele 24
SK - Slovacchia (Repubblica Slovacca) 23
TN - Tunisia 23
CO - Colombia 20
EC - Ecuador 19
PH - Filippine 19
UZ - Uzbekistan 19
MA - Marocco 18
DZ - Algeria 17
IQ - Iraq 17
TW - Taiwan 16
NZ - Nuova Zelanda 14
SI - Slovenia 12
BD - Bangladesh 11
NO - Norvegia 11
VE - Venezuela 11
HR - Croazia 9
HU - Ungheria 9
BO - Bolivia 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
AZ - Azerbaigian 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AM - Armenia 6
NG - Nigeria 6
PA - Panama 6
JO - Giordania 5
KZ - Kazakistan 5
LB - Libano 5
MK - Macedonia 5
MO - Macao, regione amministrativa speciale della Cina 5
SY - Repubblica araba siriana 5
CU - Cuba 4
KE - Kenya 4
KG - Kirghizistan 4
SA - Arabia Saudita 4
UG - Uganda 4
BY - Bielorussia 3
CR - Costa Rica 3
PY - Paraguay 3
SM - San Marino 3
BF - Burkina Faso 2
BJ - Benin 2
ET - Etiopia 2
JM - Giamaica 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MN - Mongolia 2
NP - Nepal 2
OM - Oman 2
UY - Uruguay 2
A1 - Anonimo 1
Totale 53.748
Salva come PNG Salva come JPEG
Città #
Southend 4.412
Fairfield 3.399
Santa Clara 3.311
Woodbridge 2.606
Ashburn 2.177
Chandler 2.099
Houston 2.048
Jacksonville 1.985
Dearborn 1.555
Hong Kong 1.308
Seattle 1.208
Wilmington 1.186
Ann Arbor 1.175
Cambridge 1.101
Singapore 1.065
Nyköping 950
London 929
Beijing 591
Modena 439
Princeton 412
Sofia 373
Izmir 366
Eugene 355
San Diego 327
New York 286
Hefei 276
Helsinki 272
Milan 238
Redwood City 219
Council Bluffs 203
Moscow 199
Jakarta 126
Des Moines 119
Rome 117
The Dalles 99
Falls Church 84
Dong Ket 80
Shanghai 80
Falkenstein 75
Bologna 72
Dublin 69
Norwalk 59
Naples 57
Istanbul 55
Nanjing 51
Boardman 50
Toronto 50
Brussels 47
Madrid 46
São Paulo 46
Florence 42
Kunming 42
Frankfurt am Main 41
Amsterdam 40
Guangzhou 37
Los Angeles 37
Jinan 35
Seoul 35
Leipzig 33
Nuremberg 33
Parma 33
Verona 33
Kilburn 32
Turin 30
Ottawa 29
Nanchang 28
Paris 28
Perugia 27
Bangkok 26
Buenos Aires 25
Chicago 25
Belgrade 24
Chiswick 24
Hounslow 23
Munich 23
Fremont 22
Rio de Janeiro 22
Zhengzhou 22
Belo Horizonte 21
Tokyo 21
Dallas 20
Reggio Emilia 20
Brasília 19
San Mateo 19
Auburn Hills 18
Barcelona 18
Chongqing 18
Indiana 18
Kraków 18
Mountain View 18
Philadelphia 18
Saint Petersburg 18
San Francisco 18
Seongnam-si 18
Stockholm 18
Tashkent 18
Bari 17
Monterrey 17
Salvador 17
Sydney 17
Totale 39.707
Salva come PNG Salva come JPEG
Nome #
BIOCHIMICA STRUTTURALE, FUNZIONALE E METABOLICA 911
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 564
Two analytical approaches to the evaluation of chondroitin sulfate in european food supplements. 500
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 442
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 415
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 360
ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly 342
A 96-well assay for uronic acid carbazole reaction 307
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 304
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 261
12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment. 250
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 244
Le arilsolfatasi come glicoconiugati: aspetti biochimico - comparati della loro regolazione 242
Chondroitin Sulfate and Glucosamine as Disease Modifying Anti- Osteoarthritis Dru gs (DMOADs). 239
Beta-amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. 238
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 237
Plasmatic and urinary glycosaminoglycans characterization in mucopolysaccharidosis II Patient treated with enzyme-replacement therapy with Idursulfase 234
Glycosaminoglycan Blotting and Detection After Electrophoresis Separation 231
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 230
Capillary blotting of glycosaminoglycans on nitrocellulose membranes after agarose-gel electrophoresis separation 230
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 225
Isolation and structural characterization of chondroitin sulfate from bony fishes 223
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 215
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 213
Comparative analysis of fatty acid profile in three eutardigrade species 213
Separation of flavonoids and phenolic acids from propolis by capillary zone electrophoresis 212
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 212
Recent advances on separation and characterization of human milk oligosaccharides. 211
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 210
Shockwave lithotripsy and the protective role of inosine: Early and late evaluation in an experimental model 209
Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations 208
Human Milk Glycosaminoglycans Inhibit in vitro the Adhesion of Escherichia coli and Salmonella fyris to Human Intestinal Cells 208
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 206
Composition and structure elucidation of human milk glycosaminoglycans 204
Glycosaminoglycan content in term and preterm milk during the first month of lactation 203
Shift of optimal pH in arylsulphatase from Mollusca depending on temperature 202
Capillary electrophoresis of bacterial (lipo)polysaccharides 202
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 201
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 200
effects of glycosaminoglycans on u-937 leukemia-cell proliferation and differentiation - structure-function relationship 199
Adsorption of glycosaminoglycans onto coral - a new possible implant biomaterials for regeneration therapy 198
I glicosaminoglicani: struttura, funzioni, tecniche analitiche di indagine, e loro modificazioni in valvole mitraliche ed aortiche di soggetti affetti da patologia degenerativa 198
Electrophoresis for the analysis of heparin purity and quality. 197
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 196
The protein profile of fibroblasts: the role of proteomics. 195
Different analyses measure chondroitin pharmacokinetics. 195
Safety assessment of non-animal chondroitin sulfate sodium: Subchronic study in rats, genotoxicity tests and human bioavailability. 193
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 193
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 192
Determination of urinary hexosamines for diagnosis of bladder pain syndrome 192
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 192
Chondroitin sulfate structure is modified in human milk produced by breast affected by invasive carcinoma. 191
Analysis of flavonoids from propolis by on-line HPLC-electrospray mass spectrometry 188
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 188
Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects 188
Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model 188
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 188
activity of chondroitin ABC lyase on dermatan sulfate partially degraded by cupric-ion-mediated free-radical treatment 187
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 186
Electrophoretic approaches to the analysis of complex polysaccharides 185
Human milk glycosaminoglycans: the state of the art and future perspectives 185
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 185
Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma 185
Stability studies of chondroitin sulfate 185
High-performance capillary electrophoresis separation of hyaluronan oligosaccharides produced by Streptomyces hyalurolyticus hyaluronate lyase 184
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 184
Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum 184
Studies on European eel skin sulfated glycosaminoglycans: Recovery, structural characterization and anticoagulant activity 184
Fine characterization of mitral valve glycosaminoglycans and their modification with degenerative disease. 181
Composition of urinary glycosaminoglycans in a patient with pseudoxanthoma elasticum and familial Mediterranean fever 181
Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE) 181
Chondroitin sulfate. Structure, role and pharmacological activity. Nicola Volpi (Editor) 181
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 179
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses 178
IMPLICANCIA DE LAS CADENAS DE GLICOSAMINOGLICANOS DE LA MATRIZ EXTRACELULAR EN LA “ATERO-RESISTENCIA” VASCULAR. 178
Effect of holder pasteurisation on human milk glycosaminoglycans 177
Oral bioavailability of chondroitin sulfate (Condrosulf (R)) and its constituents in healthy male volunteers 176
Regulation of arylsulphatases: inhibition of arylsulphatase from Haliotis rufusensis by phosphoric esters and shift of optimal pH depending on temperature 176
Effect of nonanimal high- and low-molecular-mass chondroitin sulfates produced by a biotechnological process in an animal model of polyarthritis 176
Anti-zika virus and anti-usutu virus activity of human milk and its components 176
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 175
Comparison of CPC and CETAB extractive procedures for quantification and characterization of human urinary glycosaminoglycans 175
Analytical aspects of pharmaceutical grade chondroitin sulfates 175
On-line high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry profiling of human milk oligosaccharides derivatized with 2-aminoacridone 175
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 175
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 175
Purification and characterization of hyaluronic acid from the mollusc bivalve Mytilus galloprovincialis 174
Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site 174
Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose gel electrophoresis and blotting on cetylpyridinium chloride-treated nitrocellulose membranes 174
Localization and expression of CHST6 and keratan sulfate proteoglycans in the human cornea 174
Evaluation of chondroitin sulfate bioactivity in hippocampal neurones and the astrocyte cell line U373: Influence of position of sulfate groups and charge density 174
Characterization of a low-sulfated chondroitin sulfate isolated from the hemolymph of the freshwater snail Planorbarius corneus 173
Hyaluronan in medical practice 173
Influence of charge density, sulfate group position and molecular mass on adsorption of chondroitin sulfate onto coral 172
Simultaneous detection of submicrogram quantities of hyaluronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and Stains-All 172
Disaccharide mapping of chondroitin sulfate of different origins by high-performance capillary electrophoresis and high-performance liquid chromatography 169
Recenti approcci analitici per la valutazione della qualità della propoli 169
Adenylate pool and energy charge in human lymphocytes and granulocytes irradiated at 632 nm (HeNe laser) 169
Effect of low-frequency electromagnetic pulsed field stimulation on yeast fermentation in presence of dicarboxylic and tricarboxylic acids 169
1H and 13C Characterization of Chondroitin Sulphate from Porcine Trachea and Shark Cartilage 169
Totale 21.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 217.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020905 0 0 0 0 0 0 0 0 0 0 553 352
2020/20217.420 1.143 230 491 506 674 824 662 879 358 842 434 377
2021/20225.715 214 842 516 423 158 311 311 250 717 461 800 712
2022/20236.168 691 581 425 543 684 900 183 688 819 74 285 295
2023/20244.537 227 280 197 570 1.040 350 394 584 128 134 213 420
2024/202510.970 517 192 222 966 2.496 1.887 773 1.090 1.540 896 391 0
Totale 54.197